ASCO GU Symposium 2021

Enfortumab Vedotin as Third-Line Treatment Improves Overall Survival for Patients with Advanced Urothelial Carcinoma...

March 26, 2021

The phase 3 EV-301 trial reported enfortumab vedotin prolonged overall survival (OS) among patients who had previously received chemotherapy and checkpoint inhibitors for advanced...

Lenvatinib plus Pembrolizumab Improves Overall Survival Compared to Sunitinib as First-Line Treatment for Advanced...

March 26, 2021

Adjuvant Nivolumab Improves Disease-Free Survival for Patients with Muscle-Invasive Urothelial Carcinoma in CheckMate 274

March 26, 2021

Cabozantinib Improves Progression-Free Survival over Sunitinib for Metastatic Papillary RCC in SWOG 1500

March 26, 2021

Predicting Early Metastasis in Young Men with Prostate Cancer, Cabazitaxel, Circulating Tumor Cells Are Associated with Survival and Prognosis for Men Receiving Third-line Treatment for Metastatic Castration-resistant Prostate Cancer

Circulating Tumor Cells Are Associated with Survival and Prognosis for Men Receiving Third-line Treatment...

February 22, 2021

177Lu-PSMA-617 Improves Progression-free Survival and Patient-reported Outcomes Compared to Cabazitaxel for Men with Metastatic...

February 22, 2021

Relugolix Effectively Suppresses Testosterone Levels Regardless of Other Simultaneous Prostate Cancer Treatments

February 22, 2021

Enzalutamide Provides Similar Clinical Benefit for Men with Metastatic Hormone-sensitive Prostate Cancer Due to...

February 22, 2021

Curated Journal reading List

Mucosal coaptation technique for early urinary continence after robot-assisted radical prostatectomy: a comparative exploratory...

January 27, 2022

Influence of operative time and blood loss on surgical margins and functional outcomes for...

January 27, 2022

Cognitive Ability as a Non-modifiable Risk Factor for Post-prostatectomy Urinary Incontinence: A Double-Blinded, Prospective,...

January 27, 2022

Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance:...

January 27, 2022

Patient participation in treatment decision-making of prostate cancer: a qualitative study

January 27, 2022

Highly portable quantitative screening test for prostate-specific antigen at point of care

January 27, 2022

Diagnostic value of full-length femur radiographs in patients with neck of femur fracture and...

January 27, 2022

What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance?...

January 27, 2022

Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines...

January 27, 2022

ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype...

January 27, 2022

Expert Interviews

How Racial Disparity and COVID-19 Affect Prostate Cancer Research, with Scott...

December 1, 2020

Oliver Sartor, MD, on Active Surveillance for Prostate Cancer in African...

November 24, 2020